ScholarIQanswers from OpenAlex & ORCID
Henry W. Long
ResearcherPublications, citations & collaboration network
Henry W. Long is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Henry W. Long have?
ScholarIQindexed works
Henry W. Long has 650 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Henry W. Long have?
ScholarIQcitation count
Henry W. Long has 12,942 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Henry W. Long?
ScholarIQh-index
Henry W. Long has an h-index of 57 in OpenAlex.
What is the i10-index of Henry W. Long?
ScholarIQi10-index
Henry W. Long has an i10-index of 112 in OpenAlex.
What is the ORCID of Henry W. Long?
ScholarIQorcid
The ORCID for Henry W. Long is on the source record.
What is the OpenAlex record for Henry W. Long?
ScholarIQopenalex
The OpenAlex for Henry W. Long is on the source record.
What are the most-cited papers on Henry W. Long?
ScholarIQmost cited works
<i>Rb1</i> and <i>Trp53</i> cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng‐Yu Ku, Spencer R. Rosario, Yanqing Wang, Ping Mu, Mukund Seshadri, Zachary Goodrich, Maxwell M. Goodrich, David P. Labbé, Eduardo Cortes Gomez, Jianmin Wang, Henry W. Long, Bo Xu, Myles Brown, Massimo Loda, Charles L. Sawyers, Leigh Ellis, David W. Goodrich
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
Deng Pan, Aya Kobayashi, Peng Jiang, Lucas Ferrari de Andrade, Rong En Tay, Adrienne Luoma, Daphne Tsoucas, Xintao Qiu, Klothilda Lim, Prakash K. Rao, Henry W. Long, Guo‐Cheng Yuan, John G. Doench, Myles Brown, X. Shirley Liu, Kai W. Wucherpfennig
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu, Charles Y. Lin, Housheng Hansen He, Robert M. Witwicki, Doris P. Tabassum, Justin M. Roberts, Michalina Janiszewska, Sung Jin Huh, Yi Liang, Jeremy Ryan, Ernest Doherty, Hisham Mohammed, Hao Guo, Daniel G. Stover, Muhammad B. Ekram, Guillermo Peluffo, Jonathan D. Brown, Clive S. D’Santos, Ian E. Krop, Deborah Dillon, Michael R. McKeown, Christopher J. Ott, Jun Qi, Min Ni, Prakash K. Rao, Melissa Duarte, Shwu-Yuan Wu, Cheng-Ming Chiang, Lars Anders, Richard A. Young, Eric P. Winer, Antony Letai, William T. Barry, Jason S. Carroll, Henry W. Long, Myles Brown, X. Shirley Liu, Clifford A. Meyer, James E. Bradner, Kornélia Polyák
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz, Fugen Li, David Y. Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vázquez, Jennifer Cook, Ramesh A. Shivdasani, Michaela Bowden, Rosina T. Lis, William C. Hahn, Philip W. Kantoff, Myles Brown, Massimo Loda, Henry W. Long, Matthew L. Freedman
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi, Erik H. Knelson, Yingtian Xie, Klothilda Lim, Paloma Cejas, Andrew Portell, Patrick H. Lizotte, Scott B. Ficarro, Shuai Li, Ting Chen, Heidi M. Haikala, Haiyun Wang, Magda Bahcall, Yang Gao, Sophia Z. Shalhout, Steffen Boettcher, Bo Hee Shin, Tran C. Thai, Margaret K. Wilkens, Michelle Tillgren, Mierzhati Mushajiang, Man Xu, Jihyun Choi, Arrien A. Bertram, Benjamin L. Ebert, Rameen Beroukhim, Pratiti Bandopadhayay, Mark M. Awad, Prafulla C. Gokhale, Paul T. Kirschmeier, Jarrod A. Marto, Fernando D. Camargo, Rizwan Haq, Cloud P. Paweletz, Kwok‐Kin Wong, David A. Barbie, Henry W. Long, Nathanael S. Gray, Pasi A. Jänne